Compare ICGN to:
After Hours: 0.00 N/A (N/A) 7:00pm ET
| Last Trade: | 0.44 |
|---|---|
| Trade Time: | Dec 15 |
| Change: | 0.00 (0.00%) |
| Prev Close: | 0.44 |
| Open: | N/A |
| Bid: | 0.10 x 500 |
| Ask: | 0.58 x 400 |
| 1y Target Est: | 4.00 |
| Day's Range: | N/A - N/A |
|---|---|
| 52wk Range: | 0.31 - 1.59 |
| Volume: | 0 |
| Avg Vol (3m): | 87,307.7 |
| Market Cap: | 20.76M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.28 |
| Div & Yield: | N/A (N/A) |
| Fri, Dec 11 | ICAGEN INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial StatementsEDGAR Online |
| Wed, Dec 9 | Former Glaxo CEO Charles Sanders joins BioCryst boardat bizjournals.com |
| Tue, Dec 1 | Icagen to Present at the 63rd Annual Meeting of the American Epilepsy SocietyGlobeNewswire |
| Fri, Nov 13 | Icagen gets 180 days to regain Nasdaq complianceAP |
| Fri, Nov 13 | ICAGEN INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; TransfEDGAR Online |
| Fri, Nov 13 | Icagen Reports Receipt of Notification from NASDAQ Regarding Non-Compliance With Continued Listing RequirementsGlobeNewswire |
| Fri, Nov 13 | ICAGEN INC FinancialsEDGAR Online Financials |
| Mon, Nov 9 | ICAGEN INC Files SEC form 10-Q, Quarterly ReportEDGAR Online |
| Thu, Nov 5 | Icagen narrows 3Q loss, but revenue plungesat bizjournals.com |
| Thu, Nov 5 | Icagen Inc Earnings Call scheduled for 10:00 am ET todayCCBN |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.